KRYS - Wall Street Estimates - Krystal Biotech, Inc.

Healthcare - Biotechnology - NASDAQ - US

$ 175.65

-2.01 %

$ 5.06 B

Market Cap

58.55

P/E

Price Target Average

18.84%

Revenue Forecast Estimate

62.91%

EBIT Estimate

153.38%

Net Income Estimate

80.65%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Krystal Biotech, Inc.

Wall Street analysts predict an average 1-year price target for KRYS of $209 , with forecasts ranging from a low of $204 to a high of $220 .

KRYS Lowest Price Target Wall Street Target

204 USD 16.14%

KRYS Average Price Target Wall Street Target

209 USD 18.84%

KRYS Highest Price Target Wall Street Target

220 USD 25.25%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free